Ditzinger Felix, Dejoie Catherine, Sisak Jung Dubravka, Kuentz Martin
Department of Pharmaceutical Sciences, University of Basel, 4056 Basel, Switzerland.
Institute of Pharma Technology, University of Applied Sciences and Arts Northwestern Switzerland, Hofackerstr. 30, 4132 Muttenz, Switzerland.
Pharmaceutics. 2019 Apr 10;11(4):174. doi: 10.3390/pharmaceutics11040174.
Solid dispersions are important supersaturating formulations to orally deliver poorly water-soluble drugs. A most important process technique is hot melt extrusion but process requirements limit the choice of suitable polymers. One way around this limitation is to synthesize new polymers. However, their disadvantage is that they require toxicological qualification and present regulatory hurdles for their market authorization. Therefore, this study follows an alternative approach, where new polymeric matrices are created by combining a known polymer, small molecular additives, and an initial solvent-based process step. The polyelectrolyte, carboxymethylcellulose sodium (NaCMC), was tested in combination with different additives such as amino acids, meglumine, trometamol, and urea. It was possible to obtain a new polyelectrolyte matrix that was viable for manufacturing by hot melt extrusion. The amount of additives had to be carefully tuned to obtain an amorphous polymer matrix. This was achieved by probing the matrix using several analytical techniques, such as Fourier transform infrared spectroscopy, differential scanning calorimetry, hot stage microscopy, and X-ray powder diffraction. Next, the obtained matrices had to be examined to ensure the homogeneous distribution of the components and the possible residual crystallinity. As this analysis requires probing a sample on several points and relies on high quality data, X-ray diffraction and starring techniques at a synchrotron source had to be used. Particularly promising with NaCMC was the addition of lysine as well as meglumine. Further research is needed to harness the novel matrix with drugs in amorphous formulations.
固体分散体是口服递送难溶性药物的重要过饱和制剂。最重要的工艺技术是热熔挤出,但工艺要求限制了合适聚合物的选择。克服这一限制的一种方法是合成新的聚合物。然而,它们的缺点是需要进行毒理学鉴定,并且在市场授权方面存在监管障碍。因此,本研究采用了另一种方法,即通过将一种已知聚合物、小分子添加剂和一个基于溶剂的初始工艺步骤相结合来创建新的聚合物基质。对聚电解质羧甲基纤维素钠(NaCMC)与不同添加剂(如氨基酸、葡甲胺、氨丁三醇和尿素)的组合进行了测试。有可能获得一种可通过热熔挤出制造的新型聚电解质基质。必须仔细调整添加剂的用量以获得无定形聚合物基质。这是通过使用几种分析技术(如傅里叶变换红外光谱、差示扫描量热法、热台显微镜和X射线粉末衍射)对基质进行探测来实现的。接下来,必须对获得的基质进行检查,以确保各组分的均匀分布以及可能存在的残余结晶度。由于这种分析需要在多个点对样品进行探测并依赖高质量数据,因此必须使用同步加速器源的X射线衍射和星芒技术。对于NaCMC来说,添加赖氨酸以及葡甲胺特别有前景。需要进一步研究以将这种新型基质与无定形制剂中的药物结合使用。